Amgen : AMGN

All Amgen Articles

701 Articles

Chris Lange | Oct 27, 2019 at 6:55 AM EDT

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

24/7 Wall St. has put together a preview of AT&T, Facebook, T-Mobile and the other most prominent earnings reports due…

Chris Lange | Oct 25, 2019 at 10:05 AM EDT

Major Biotechs See Rising Tide in Short Interest

The October 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 18, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap,…

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Chris Lange | Oct 10, 2019 at 10:00 AM EDT

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data…

Chris Lange | Sep 25, 2019 at 9:30 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Lee Jackson | Sep 23, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Disney, Edwards Lifesciences, Occidental and More

Monday's top analyst upgrades, downgrades and initiations included Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Edwards Lifesciences, Occidental Petroleum and…

Chris Lange | Sep 12, 2019 at 8:40 AM EDT

Major Biotechs Scare Off Short Sellers

The August 30 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 9, 2019 at 3:55 PM EDT

Amgen’s Lung Cancer Study Needs to Take a Breather

Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data…

Jon C. Ogg | Aug 29, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, Bank of America, Box, Chico’s FAS, Microsoft, Netflix, NXP, StoneCo, Tiffany and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Amgen, Bank of America, Box, Chico's FAS, Microsoft, Netflix,…

Jon C. Ogg | Aug 28, 2019 at 11:20 AM EDT

7 Giant Mergers Transforming the Face of Corporate America

Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and…

Chris Lange | Aug 27, 2019 at 9:15 AM EDT

Short Sellers Hike Their Bets in Biotech

The August 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Aug 27, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, BorgWarner, Chipotle, Cree, Dollar General, Exelon, PDC Energy, Verizon, Zynga and More

The top analyst upgrades, downgrades and initiations for Tuesday included Amgen, BorgWarner, Chipotle Mexican Grill, Cree, Dollar General, Exelon, PDC…

Chris Lange | Aug 26, 2019 at 3:20 PM EDT

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made…

1 … 11 12 13 14 15 … 47

Amgen : AMGN

All Amgen Articles

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Major Biotechs See Rising Tide in Short Interest

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Disney, Edwards Lifesciences, Occidental and More

Major Biotechs Scare Off Short Sellers

Amgen’s Lung Cancer Study Needs to Take a Breather

Top Analyst Upgrades and Downgrades: Amgen, Bank of America, Box, Chico’s FAS, Microsoft, Netflix, NXP, StoneCo, Tiffany and More

7 Giant Mergers Transforming the Face of Corporate America

Short Sellers Hike Their Bets in Biotech

Top Analyst Upgrades and Downgrades: Amgen, BorgWarner, Chipotle, Cree, Dollar General, Exelon, PDC Energy, Verizon, Zynga and More

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Amgen : AMGN

All Amgen Articles

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Major Biotechs See Rising Tide in Short Interest

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Short Sellers Hike Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Disney, Edwards Lifesciences, Occidental and More

Major Biotechs Scare Off Short Sellers

Amgen’s Lung Cancer Study Needs to Take a Breather

Top Analyst Upgrades and Downgrades: Amgen, Bank of America, Box, Chico’s FAS, Microsoft, Netflix, NXP, StoneCo, Tiffany and More

7 Giant Mergers Transforming the Face of Corporate America

Short Sellers Hike Their Bets in Biotech

Top Analyst Upgrades and Downgrades: Amgen, BorgWarner, Chipotle, Cree, Dollar General, Exelon, PDC Energy, Verizon, Zynga and More

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.